LUCIUS LAMPTON: Open Payments
NPI 1689781007 · MAGNOLIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 15 payments from 6 companies in 2025. Trend: 2023 $346 · 2024 $214 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $153 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lundbeck LLC | 2 | $37 |
| Verona Pharma, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: REXULTI, TRELEGY ELLIPTA, BREZTRI, Ohtuvayre, AUSTEDO XR.
Industry payments across MS — which companies pay providers there.
